Secondary Logo

Journal Logo

Original Article

Voltage-dependent block of neuronal and skeletal muscle sodium channels by thymol and menthol

Haeseler, G.*; Maue, D.*; Grosskreutz, J.; Bufler, J.; Nentwig, B.*; Piepenbrock, S.*; Dengler, R.; Leuwer, M.

Author Information
European Journal of Anaesthesiology: August 2002 - Volume 19 - Issue 8 - p 571-579



Naturally occurring phenolic monoterpenes, e.g. thymol, eugenol and carvacrol, are the active ingredients in the essential oils of plants occurring in the Mediterranean flora [1-5]. Several beneficial effects have been ascribed to these essential oils, among others their strong bactericidal and antifungal activity [2,6-9] and their anti-inflammatory properties [1,10-12]. In addition, aromatic alcohols with intact phenolic groups and different phenol derivatives have been shown to act as scavengers of reactive oxygen species, thus protecting neurons effectively against oxidative damage and cell death [13]. Dietary supplementation with thyme oil even tended to prevent age-related changes in the phospholipid composition in several organs in rats [14,15].

Antinociceptive and local anaesthetic effects have long been described for L-menthol [16], eugenol and thymol [11]; however, a precise molecular target site for these effects has not yet been identified. It has recently been shown that phenol derivatives, among others the anaesthetic propofol (2,6-diisopropylphenol), are potent blockers of heterologously expressed voltage-operated sodium channels in vitro[17-19]. The close structural relationship between the anaesthetic propofol (2,6-diisopropyl-phenol) and the naturally occurring phenol derivative thymol (5-methyl-2-isopropyl-phenol) gave rise to the hypothesis that the antinociceptive effects described for this compound might be mediated via blockade of voltage-operated sodium channels analogous to the effects describe for other phenol derivatives and local anaesthetics (Fig. 1).

Figure 1
Figure 1:
Structures of thymol (5-methyl-2-isopropyl-phenol), menthol (5-methyl-2-isopropyl-cyclohexanol) and the anaesthetic propofol (2,6-diisopropyl-phenol).

We investigated the effects of thymol (5-methyl-2-isopropyl-phenol) and its structural homologue menthol (5-methyl-2-isopropyl-cyclohexanol) on heterologously expressed α-subunits of rat brain IIA and human skeletal muscle (hSkM1) sodium channels as possible targets contributing to the local anaesthetic and antinociceptive activity of the drugs. The α-subunit is the primary pore-forming subunit of voltage-operated sodium channels and it functions as an ion channel when expressed alone [20]. α-Subunits of rat brain IIA and hSkM1 sodium channels show normal gating characteristics (with respect to experiments in native tissue) when expressed in a mammalian cell line [21,22]. The rat brain IIA form is most abundant in adult brain [23], hSkM1 is the principal voltage-gated sodium channel expressed in adult human skeletal muscle [24].


Transfection and cell culture

Stably transfected HEK 293 cell lines expressing either the α-subunit of rat brain IIA or hSkM1 sodium channels were a gift from Professor Lehmann-Horn, Ulm, Germany. The expression vector pRc/CMV® (Invitrogen, San Diego, CA, USA) was used for mammalian transfection [25]. Transfection was performed using calcium phosphate precipitation [26]. Permanent expression was achieved by selection for resistance to the aminoglycoside antibiotic geneticin G418® (Life Technology, Eggenstein, Germany) [25]. Successful channel expression was verified electrophysiologically. The clones have been used in several investigations [22,25,27].


Thymol and menthol were prepared as a 1 mol stock solution in ethanol, light protected and stored in glass vessels at −20°C. The stock solution was dissolved directly in a bath solution immediately before the experiments. Drug-containing vials were vigorously vortexed for 60 min. The solution was applied via a glass-polytetrafluoroethylene perfusion system and a stainless-steel superfusion pipette. The bath solution contained NaCl 140 mmol, MgCl2 1 mmol, KCl 4 mmol, CaCl2 2 mmol, Hepes 5 mmol and dextrose 5 mmol. Patch electrodes contained CsCl2 130 mmol, MgCl2 2 mmol, EGTA 5 mmol and Hepes 10 mmol. All solutions were adjusted to 290 mOsm by addition of mannitol, and to pH 7.4 by addition of CsOH.


Standard whole cell voltage-clamp experiments [28] were performed at 20°C. Each experiment consisted of test recordings with the drug present at only one concentration, and of drug-free control recordings before and after the test. Each cell was exposed to one test concentration only. At least four experiments were performed at each concentration. The effects of the diluent ethanol corresponding to higher drug concentrations were tested separately up to a maximum ethanol concentration of 17.4 mmol corresponding to a drug concentration of 1000 μmol.

For data acquisition and further analysis, we used the EPC9® digitally controlled amplifier in combination with Pulse® and Pulse Fit® software (HEKA Electronics, Lambrecht, Germany). The EPC9® provides automatic subtraction of capacitive and leakage currents by means of a prepulse protocol. The data were filtered at 10 kHz and digitized at 20 μs per point. Input resistance of the patch pipettes was at 1.8-2.5 MΩ, cells capacitances ranged between 9 and 15 pF; and residual series resistance (after 50% compensation) was 1.2-2.5 MΩ. Experiments with a rise in series resistance were rejected. Voltage-activated currents were studied by applying different voltage-clamp protocols, as described in the Results or in the appropriate Figure legends.

Hyperpolarizing shifts in the voltage dependence of steady state availability as a function of the recording time, which may reach −6 mV after 10 min of wholecell recording [29], may pose a problem when considering drug effects on current-voltage relationships. To avoid a biasing of the test results, all test experiments were performed within 5 min of patch rupture. During the first 5 min of whole-cell recording, time-dependent hyperpolarizing shifts in control conditions were less than −2 mV [27]. Washout of drug effects on the voltage dependence of channel availability was considered successful when the drug-induced shift changed its direction during washout and when the difference in the mid-point of the availability curve between the starting value and that obtained during washout did not largely exceed −6 mV.

Drug effects on the peak current amplitude were assessed at a holding potential of −70 mV, which is close to the resting potential found in single muscle fibres of frog semitendinosus muscle after equilibration with an external potassium concentration of 5.0 mmol in vitro (−76 ± 2 mV) [30], and at hyperpolarized holding potentials (−100 and −150 mV). The residual sodium current (INa+) in the presence of drug (with respect to the current amplitude in control solution) was plotted against the applied concentration of each drug [C]. As each cell was exposed to one test concentration only, each datum point represents the mean derived from at least four different experiments, error bars are SD. Fits of the Hill equation: EQUATION 1

to the averaged data yielded the concentration for half-maximum channel blockade (IC50) and the Hill coefficient nH.

A one-sample t-test was applied to analyse the significance of changes in gating parameters in the presence of drug with respect to the starting value. To avoid problems related to multiple hypotheses testing, we applied the method of multiple comparisons with a priori-ordered hypotheses [31]. The test is based on the assumption that if the null hypothesis is rejected, there is a positive monotonic relation between concentration and effect. Consequently, the hypotheses to be tested could be ordered in advance, starting with the highest concentration. If the test results differed significantly from the control data, the effects of the next, lower concentration were evaluated. The evaluation was stopped as soon as the first insignificant result was obtained. The advantage of this procedure, compared with other approaches to multiple testing, is that the level of Type I error is kept at α = 0.05 for each statistical test. The null hypothesis was rejected when P < 0.05.


Resting state affinity

Seventy-five cells were included in the study. Average currents in the control experiments following depolarization from −100 to 0 mV were −2.9 ± 1.2 nA for the skeletal muscle isoform and −3.7 ± 1.4 nA for the neuronal isoform. Maximum inward currents elicited by 10 ms pulses from either −150, −100 or −70 to 0 mV were reversibly suppressed by thymol and menthol in a concentration-dependent manner. Figure 2 shows representative current traces in the absence and presence of either 100 μmol thymol or 500 μmol menthol. Normalized currents (with respect to control), derived from at least four different experiments for each drug concentration, were averaged to establish concentration-response plots. The amount of block achieved by either thymol or menthol strongly depended on the holding potential from which the depolarization was started. Hill fits to the averaged data obtained for thymol (Fig. 3) yielded IC50 of 149 and 104 μmol at −70 mV, 366 and 222 μmol at −100 mV, and 410 and 245 μmol at −150 mV holding potential for the neuronal and skeletal muscle isoform, respectively.

Figure 2
Figure 2:
Representative current traces following 10 ms depolarization from −100 to 0 mV in the absence (control and wash-out) and presence of either 100 μmol thymol or 500 μmol menthol in the skeletal muscle isoform.
Figure 3
Figure 3:
Concentration-dependent reduction in the test pulse current achieved by thymol with respect to control in both channel isoforms. Each datum point represents the mean (±SD) of normalized currents derived from at least four experiments for each concentration tested. Depolarizing pulses to 0 mV (10 ms duration) were started from either −150, −100 or −70 mV. Solid lines are Hill fits to the averaged data. The concentration-response plots at −100 and −150 mV are nearly superimposible (▵, ♦), while the blocking potency of both compounds was increased when depolarizations were started from −70 mV (▪).

Fitted Hill coefficients nH were 1.13 and 1.09 (−70 mV), 1.56 and 1.49 (−100 mV), and 2.87 and 1.62 (−150 mV). Menthol was less potent than thymol, the half-maximum blocking concentrations being 571 and 376 μmol at −70 mV, 1150 and 783 μmol at −100 mV, and 1215 and 792 μmol at −150 mV holding potential for the neuronal and skeletal muscle isoform, respectively.

Blocking effects were generally reversible on washout, when washout was incomplete, currents in the presence of drug were normalized to the current amplitude during washout.

At a concentration of 17.4 mmol, corresponding to a drug concentration of 1000 μmol, the diluent ethanol had a small effect on the peak current amplitude at −150 mV holding potential. The peak current was −2.2 ± 0.1 nA in the controls and −2.3 ± 0.1 nA in the presence of 8.7 mmol (n = 3), and −2.8 ± 0.2 in the controls and −2.3 ± 0.1 nA in the presence of 17.4 mmol ethanol (n = 3). This means that in drug concentrations > 1000 μmol, the diluent ethanol contributes to the peak current suppression induced by the test solution by approximately 16%.

Inactivated state affinity

The increase in blocking potency at a holding potential of −70 mV, where some of the channels are inactivated, compared with −150 mV, where all channels are expected to be in the resting state, suggests that the amount of block achieved by either thymol or menthol depends on the membrane potential and is increased with an increased fraction of inactivated channels with respect to resting channels. The voltage dependence of block and affinity for the inactivated state was further assessed by applying a double-pulse protocol. After brief depolarizations, sodium channels enter a fast-inactivated state from which they cannot readily reopen. Currents elicited by test pulses (Itest) starting from varying prepulse potentials (from −150 to −5 mV) to 0 mV, normalized to the current elicited at the most hyperpolarized prepotential (−150 mV), represent the relative fraction of channels that have not been inactivated during the 50 ms inactivating prepulse. Boltzmann fits to the resulting current-voltage plots yield the membrane potential at half-maximum channel availability (V0.5) and the slope factor k:EQUATION 2

In control conditions, the parameters of the Boltzmann fits reflect the voltage dependence of the distribution between resting and fast-inactivated channels.

Summarized control data showed that half of the channels were unavailable at −43.4 ± 3.2 mV (rat IIA isoform) and at −59.6 ± 3.7 mV (hSkM1) because of fast inactivation. The slope factors k were 7.9 ± 1.1 and 6.9 ± 1.1, respectively. With exposure to either thymol or menthol, V0.5 was shifted considerably in the direction of more negative prepulse potentials; the degree of alteration showed concentration dependence. The averaged data for the thymol effects are depicted in Figure 4. Drug effects on the voltage dependence of channel availability were reversible during washout, taking into account that a shift of about −6 mV is expected to occur as a function of the recording time until completion of the washout experiments. For example, 200 μmol thymol shifted the mid-point of the availability curve from −39.1 ± 3.9 mV (rat IIA) and −60.2 ± 5.8 mV (hSkM1) to −51.8 ± 4.6 and −74.8 ± 6.8 mV. The values obtained during washout were −44.3 ± 3.1 and −69.1 ± 1.4 mV, respectively. The slope factors k remained unchanged in the presence of drug (Fig. 4). The drug-induced hyperpolarizing shifts reflect an additional reduction of channel availability induced by both drugs in the voltage range of channel inactivation compared with −150 mV. To estimate the dissociation constant (Kd) of thymol and menthol for the fast-inactivated state of both channel isoforms, we employed a model developed by Bean and colleagues [32] for the example of lidocaine effects on Purkinje fibres. The model is based on the assumption that the higher amount of channel block achieved with consecutive membrane depolarization, revealed by the drug-induced hyperpolarizing shift, is determined by the apportionment of channels between resting and fast-inactivated states as well as the different binding affinities for the two channel states. The concentration dependence of the shift in the mid-point was well described by the equation: EQUATION 3

Figure 4
Figure 4:
Thymol effects on fast-inactivated channels assessed by shifts in the steady-state availability curve. (a) Steady-state availability curves assessed by a two-pulse protocol in the absence (control, •) and presence of 50 and 300 μmol thymol (▴, ▪) in the skeletal muscle isoform. Each symbol represents the mean fractional current (n > 4 for each concentration) elicited by a 4 ms test pulse to 0 mV, following a 50 ms inactivating prepulse from −150 mV to the indicated prepulse potential, Currents were normalized to a maximum value (in each series at −150 mV prepotential); solid lines represent the best Boltzmann (I/Imax = (1 + exp((Vtest − V0.5)/k))−1) fit to the data yielding the membrane potential at half-maximum channel availability (V0.5) and the slope factor k. Error bars are SD. In the presence of 300 μmol thymol, currents were normalized either to a maximum value in the presence of drug (▪) or to a maximum value in the controls (□). Thymol shifted the mid-points of the curves in the direction of more negative prepulse potentials, reflecting an additional reduction in channel availability at depolarized prepotentials (compared with the block achieved at −150 mV). (b) Concentration dependence of drug-induced negative shifts in the mid-points (ΔV0.5 (mV), mean ± SD) of the steady-state availability plots relative to the starting values in both isoforms. The solid line is a least-squares fit of the equation ΔV0.5 = k × ln((1 + [C]/IC−15050) × (1 + [C]/Kd)−1) to the averaged data.

where ΔV0.5 is the shift in the mid-point in each drug concentration (mean, n > 4), k is the mean of the slope factor derived from Boltzmann fits to the current-voltage plots (see above), [C] is the applied concentration of drug, IC−15050 is the concentration for half-maximum effect derived from the concentration-response plots at −150 mV membrane potential described above, and Kd the dissociation constant for the drug from the inactivated state.

For thymol, the estimated Kd derived from that fit were 22 and 23 μmol for the neuronal and skeletal muscle isoform (Fig. 4b). For menthol, Kd was 106 and 97 μmol.

When applied instead of test solution at 17.4 mmol, corresponding to a drug concentration of 1000 μmol, the diluent ethanol did not shift the steady-state voltage dependence in the hyperpolarizing direction. In the presence of ethanol, a small positive shift of 5.0 ± 0.2 mV (n = 3) was observed.

Time-course of channel inactivation and recovery from an inactivated channel block in the presence of thymol

As other phenol derivatives have been shown to accelerate the time course of sodium channel inactivation during a depolarization, and to delay the time-course of recovery from fast inactivation [18], we studied the possible effects of thymol on inactivation-gating parameters of the neuronal and skeletal muscle isoform.

The time constant of channel inactivation τh was obtained by fitting a single exponential to the decay of current during a 40 ms depolarization from −100 to 0 mV at a holding potential of −100 mV: EQUATION 4

At least three experiments were evaluated for each concentration tested. In control conditions, τh was 0.72 ± 0.2 ms (n = 15) for rat brain IIA and 0.58 ± 0.09 ms (n = 18) for hSkM1 sodium channels. Thymol did not significantly accelerate the current decay. τh obtained in the presence of drug were: 0.61 ± 0.1 and 0.48 ± 0.1 ms in 200 μmol thymol and 0.66 ± 0.1 and 0.54 ± 0.06 ms in 100 μmol thymol in the neuronal and skeletal muscle isoform, respectively.

After inactivation, channel reopenings are impossible until the channels recover from inactivation, a process that requires several milliseconds after membrane repolarization. Further information about drug effects on the stability of the fast-inactivated state or the kinetics of drug dissociation from the fast-inactivated state can be derived from the rate at which the channels recover from inactivation in the presence of the drug. The time of membrane repolarization required to remove fast inactivation was assessed at −100 mV by a two-pulse protocol with varying time intervals (up to 100 ms) between the inactivating prepulse and the test pulse. The time constants of recovery, τrec, were derived from biexponential fits to the fractional current after recovery from inactivation plotted against the time interval between the inactivating prepulse and the test pulse: EQUATION 5

At least three experiments were evaluated for each concentration tested. Without drug, recovery time constants obtained for the neuronal (n = 17) and skeletal muscle isoform (n = 16) were τrec1 2.2 ± 0.7 and 2.6 ± 1.0 ms with a slow component τrec2 of 19.9 ± 0.9 and 19.6 ± 1 ms, which comprised 9 and 11% of the current amplitude. Thymol did not significantly increase the time constants of recovery from fast inactivation, indicating that the time-course of drug unbinding from inactivated channels is fast enough to parallel the time-course of channel gating. τrec1 in the presence of 200 μmol thymol was 2.9 ± 1.5 and 5.3 ± 0.7 ms; τrec2 was 18.3 ± 1.6 and 25.0 ± 7.1 ms. However, the slow component of recovery of about 20 ms increased in amplitude up to 30 ± 14% in 200 μmol thymol in both isoforms. This means that recovery from an inactivated channel block at a hyperpolarized holding potential (−100 mV) should be too fast to accumulate relevant frequency-dependent block at stimulating frequencies <50 Hz.

The accumulation of block during trains of depolarizing pulses indicates that the interval between pulses is too short to allow recovery of sodium-channel availability. To derive an estimate of the kinetics of drug binding and unbinding during the interpulse interval, we applied series of 1-10 ms depolarizing pulses from −100 to 0 mV at high frequencies (10, 50, 100 Hz). Frequency-dependent block was defined as the additional reduction in INa+ for the last pulse relative to the first pulse in a test train in the presence of drug. In control conditions, the amplitude of the last pulse relative to the first pulse in a test train was 99 ± 2% at 10 and 50 Hz, and 86 ± 6% at 100 Hz due to incomplete recovery from inactivation at very high stimulating frequencies. As expected, thymol did not induce frequency-dependent block over 5% at 10 and 50 Hz. Only at 100 Hz did thymol produce a small amount of frequency-dependent block. During a 100-Hz train, the additional fall relative to the first pulse was 29 ± 11% (rat brain IIA) and 30 ± 8% (hSkM1) in 200 μmol thymol.


Voltage-gated sodium channels are membrane-spanning proteins responsible for the initiation and propagation of action potentials in nerve and muscle cells. In response to membrane depolarization, the channels open from the resting, closed state and then inactivate spontaneously. The main result of the study was that thymol, and to a much lesser extent menthol, blocks voltage-gated neuronal and skeletal muscle sodium channels in a concentration-dependent manner in resting and inactivated states. The blocking potency of thymol is comparable with the blocking potency of the local anaesthetic lidocaine [33]. This effect provides the molecular basis for potential analgesic and antinociceptive effects of the compound. In vitro, the sodium channel blocking potency of thymol is higher than the potency of menthol. These results conflict with a recent study showing that local anaesthetic activity of menthol, assessed in vivo in the rabbit conjunctival reflex test and in vitro in a rat phrenic nerve hemidiaphragm preparation, was superior to thymol [34]. Thus, in the case of menthol, local anaesthetic activity in vivo might rely on other mechanisms besides blockade of voltage-operated sodium channels. Alternatively, discrepancies concerning the activity of thymol might be explained by differences in storage and application. Analogous to the structurally closely related anaesthetic propofol, thymol should be light protected and stored in glass vessels to avoid loss of activity [35].

The block of sodium channels by thymol and menthol shares many attributes with sodium channel blockade by local anaesthetic and antidysrrhythmic drugs. In analogy to lidocaine-like local anaesthetics, the blocking potency of thymol and menthol strongly depends on the kinetic state of the channel [32,36]. The affinity of both compounds for the resting state assessed at an extremely hyperpolarized holding potential (−150 mV) was more than one order of magnitude below the estimated affinity for the fast-inactivated state. Consequently, the blocking effects of both compounds were determined by the fraction of inactivated channels, which in turn depended on the respective holding potential. The maintenance of a normal resting potential of about −70 to −80 mV strongly depends on the potassium gradient [30], and thus, a proper function of the energy-dependent Na+-K+-ATPase. As a consequence, stronger effects of either thymol, menthol or lidocaine should be expected in ischaemic or hypoxically damaged tissue, where a normal resting potential cannot be maintained and membranes are more depolarized, increasing the fraction of inactivated (=high-affinity) channels.

However, following membrane repolarization, recovery from an inactivated channel block is faster in the presence of thymol compared with lidocaine (τrec(slow) 20 versus >100 ms in case of lidocaine [33]), reducing the risk of prolonged channel blockade. Thus, the integrative function of sodium channels in normal tissue can be supposed to be maintained in the presence of thymol.

Channel-gating kinetics in voltage-operated sodium channels from different tissues are similar when concerned with activation and inactivation time constants, but differ markedly in the voltage dependence of these processes [37]. Differences in the voltage dependence of inactivation between channel isoforms determine the sensitivity to blocking drugs with stronger binding affinities to inactivated compared with resting channels at a given membrane potential [38,39]. The estimated dissociation constants Kd of thymol and menthol for the inactivated state of the channel were the same for both channel isoforms, indicating that differences in blocking potency between neuronal and skeletal muscle sodium channels are explained by differences in the apportionment between resting and inactivated states at a given membrane potential, rather than differences in the inactivated state binding site. The membrane potential of half-maximum channel inactivation was −59 mV for skeletal muscle and −43 mV for the neuronal isoform in this study; thus, in the voltage range between −60 and −150 mV, the neuronal isoform should be less sensitive due to a higher fraction of resting (=low-affinity) with respect to inactivated (=high-affinity) channels.

The use of virtually all local anaesthetics is limited due to central nervous toxicity occurring with higher brain concentrations. Local anaesthetic-induced convulsions are especially attributed to the depression of inhibitory circuits in the central nervous system (CNS) [40-42]. Both local anaesthetics, phenol and its derivatives p-cresol and benzyl alcohol have been shown to inhibit voltage-operated potassium channels [43,44], one mechanism that may cause axonal hyperexcitability and convulsions in vivo. It is conceivable that the phenol derivative thymol and menthol affect potassium channels in a similar way and, thus, possess proconvulsive activities. However, while thymol and local anaesthetics both block voltage-operated ion channels, they differ profoundly in their effects on the major receptor for inhibitory neurotransmission in the mammalian brain, the γ-aminobutyric acid (GABAA-) receptor. Local anaesthetics like lidocaine, bupivacaine, procaine, benzocaine and cocaine have been shown to inhibit GABA-induced currents, one mechanism likely to contribute to central nervous toxicity of local anaesthetics [40-42]. In contrast, thymol, as well as other ortho-alkylated phenol derivatives, activates Cl currents through GABAA receptors in the absence of GABA [45], a mechanism that might contribute to the sedative activity of ortho-alkylated phenol derivatives revealed by animal experiments [46]. Results from this study suggest that the naturally occurring phenol derivative thymol might represent an interesting alternative to local anaesthetics as it can be expected to combine lidocaine-like actions due to inhibition of voltage-operated sodium channels with sedative-anticonvulsant effects due to activation of inhibitory circuits in the CNS and neuroprotective effects due to its radical scavenging properties [47]. However, further in vivo studies are required to confirm the pharmacological effects postulated from these in vitro results.

Up to now, the use of thymol in clinical practice did not take advantage of its potential analgesic or local anaesthetic effects. Thymol is still in use as halothane-stabilizing agent. High concentrations may be reached in irregularly drained vaporizers [48]. However, no reports on plasma concentrations reached in patients during halothane anaesthesia or a potential minimum alveolar concentration (MAC)-reduction in thymol-containing halothane preparations with respect to thymol-free halothane are available at present. In combination with talc, when thymol iodine was used in the treatment of recurrent malignant and non-malignant pleural effusion providing pleurodesis when installed into a chest tube, no adverse effect was observed in the treatment group [49,50].


The authors are indebted to Professor Lehmann-Horn, Ulm, for providing them with transfected cells, to Dr Hans-Peter Reiffen, Department of Anaesthesiology, Hannover, for help with software problems, to Jobst Kilian and Andreas Niesel, Department of Neurology, Hannover, for technical support, and to W. Heyde, Clinical Pharmacy, Hannover, for providing stock solutions of thymol.


1. Lorente I, Ocete MA, Zarzuelo A, Cabo MM, Jimenez J. Bioactivity of the essential oil of Bupleurum fruticosum. J Nat Prod 1989; 52: 267-272.
2. Kulevanova S, Kaftandzieva A, Dimitrovska A, Stefkov G, Grdanoska T, Panovski N. Investigation of antimicrobial activity of essential oils of several Macedonian Thymus L. species (Laminaceae). Boll Chim Farm 2000; 139: 276-280.
3. Pereira SI, Santos PA, Barroso JG, et al. Chemical polymorphism of the essential oils from populations of Thymus caespititius grown on the island S. Jorge (Azores). Phytochemistry 2000; 55: 241-246.
4. Consentino S, Tuberosa CI, Pisano B, et al. In-vitro antimicrobial activity and chemical composition of Sardinian Thymus essential oils. Lett Appl Microbiol 1999; 29: 130-135.
5. Juliani HR, Biurrun F, Koroch AR, Juliani HR, Zygadlo JA. Chemical constituents of the essential oil of Lippia laxibracteata (Verbenaceae). Planta Med 2000; 66: 567-568.
6. Evans JD, Martin SA. Effects of thymol on ruminal microorganisms. Curr Microbiol 2000; 41: 336-340.
7. Lambert RJ. Susceptibility testing: inoculum size dependency of inhibition using the Colworth MIC technique. J Appl Microbiol 2000; 89: 275-279.
8. Montes-Belmont R, Carvajal M. Control of Aspergillus flavus in maize with plant essential oils and their components. J Food Prot 1998; 61: 616-619.
9. Viollon C, Chaumont JP. Antifungal properties of essential oils and their main components upon Cryptococcus neoformans. Mycopathologica 1994; 128: 151-153.
10. Azuma Y, Ozasa N, Ueda Y, Takagi N. Pharmacological studies on the anti-inflammatory action of phenolic compounds. J Dent Res 1986; 65: 53-56.
11. Anamura S, Dohi T, Shirakawa M, Okamoto H, Tsujimoto A. Effects of phenolic dental medicaments on prostaglandin synthesis by microsomes of bovine tooth pulp and rabbit kidney medulla. Arch Oral Biol 1988; 33: 555-560.
12. Yucel-Lindberg T, Twetman S, Skold-Larsson K, Modeer T. Effect of an antibacterial dental varnish on the levels of prostanoids, leukotriene B4, and interleukin-1 beta in gingival crevicular fluid. Acta Odontol Scand 1999; 57: 23-27.
13. Uhr M, Moosmann B, Behl C. Aromatic alcohols as neuroprotectants. J Neural Transm 1998; 54 (Suppl): 287-294.
14. Youdim KA, Deans SG. Beneficial effects of thyme oil on age-related changes in the phospholipid C20 and C22 polyunsaturated fatty acid composition of various rat tissues. Biochim Biophys Acta 1999; 1438: 140-146.
15. Youdim KA, Deans SG. Effect of thyme oil and thymol dietary supplementation on the antioxidant status and fatty acid composition of the ageing rat brain. Br J Nutr 2000; 83: 87-93.
16. Taniguchi Y, Deguchi Y, Saita M, Noda K. Antinociceptive effects of counterirritants. Nippon Yakurigaku Zasshi 1994; 104: 433-446.
17. Haeseler G, Störmer M, Bufler J, et al. Propofol blocks skeletal muscle sodium channels in a voltage-dependent manner. Anesth Analg 2001; 92: 1192-1198.
18. Haeseler G, Piepenbrink A, Bufler J, et al. Structural requirements for voltage-dependent block of muscle sodium channels by phenol derivatives. Br J Pharmacol 2001; 132: 1916-1924.
19. Rehberg B, Duch D. Suppression of central nervous system sodium channels by propofol. Anesthesiology 1999; 91: 512-520.
20. Catterall WA. Cellular and molecular biology of voltage-gated sodium channels. Physiol Rev 1992; 72 (Suppl): 15-48.
21. Chahine M, Bennett P, George A, Horn R. Functional expression and properties of the human skeletal muscle sodium channel. Pflügers Arch 1994; 427: 136-142.
22. Sarkar SN, Adhikari A, Sikdar SK. Kinetic characterization of rat brain type IIA sodium channel α-subunit stably expressed in a somatic cell line. J Physiol 1995; 488: 633-645.
23. Beckh S, Noda M, Lübbert H, Numa S. Differential regulation of three sodium channel messenger RNAs in the rat central nervous system during development. EMBO J 1989; 8: 3611-3616.
24. George A, Komisarof J, Kallen R, Barchi R. Primary structure of the adult human skeletal muscle voltage-dependent sodium channel. Ann Neurol 1992; 31: 131-137.
25. Mitrovic N, George AL Jr, Heine R, et al. K(+)-aggravated myotonia: destabilization of the inactivated state of the human muscle sodium channel by the V1589M mutation. J Physiol 1994; 478: 395-402.
26. Graham FL, Van der Eb AJ. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 1973; 52: 456-467.
27. Haeseler G, Petzold J, Hecker H, et al. Succinylcholine metabolite succinic acid alters steady-state activation in muscle sodium channels. Anesthesiology 2000; 92: 1385-1392.
28. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch 1981; 391: 85-100.
29. Wang DW, George AL, Bennett PB. Comparison of heterologously expressed human cardiac and skeletal muscle sodium channels. Biophys J 1996; 70: 238-245.
30. Hodgkin AL, Horowicz P. The influence of potassium and chloride ions on the membrane potential of single muscle fibres. J Physiol 1959; 148: 127-160.
31. Maurer W. Multiple comparisons in drug clinical trials and preclinical assays: a priori ordered hypotheses. In: Vollmar J, ed. Testing Principles in Clinical and Preclinical Trials. Stuttgart, Germany: Fischer, 1995; 3-8.
32. Bean BP, Cohen CJ, Tsien RW. Lidocaine block of cardiac sodium channels. J Gen Physiol 1983; 81: 613-642.
33. Fan Z, George AL, Kyle JW, Makielski JC. Two human paramyotonia congenita mutations have opposite effects on lidocaine block of Na+ channels expressed in a mammalian cell line. J Physiol 1996; 496: 275-286.
34. Galeotti N, Ghelardini C, Mannelli L, et al. Local anaesthetic activity of (+)- and (−)-menthol. Planta Med 2001; 67: 174-176.
35. Barann M, Friedrich P, Retzmann K, Dybek A, Urban BW. Loss of propofol during in vitro experiments. Anesthesiology 2000; 93: 310-311.
36. Scheuer T. A revised view of local anesthetic action: What channel state is really stabilized? J Gen Physiol 1999; 113: 3-6.
37. Hille B. Na and K channels of axons. In: Hille B, ed. Ionic Channels of Excitable Membranes, 2nd edn. Sunderland, USA: Sinauer Associates, 1992; 59-82.
38. Wright SN, Wang SY, Kallen RG, Wang GK. Differences in steady-state inactivation between Na channel isoforms affect local anaesthetic binding affinity. Biophys J 1997; 73: 779-788.
39. Wright SN, Wang SY, Xiao YF, Wang GK. Statedependent cocaine block of sodium channel isoforms, chimeras, and channels coexpressed with the β1 subunit. Biophys J 1999; 76: 233-245.
40. Sugimoto M, Uchida I, Fukami S, et al. The α- and γ-subunit-dependent effects of local anaesthetics on recombinant GABAA receptors. Eur J Pharmacol 2000; 401: 329-337.
41. Ye JH, Liu PL, Wu WH, McArdle JJ. Cocaine depresses GABAA current of hippocampal neurons. Brain Res 1997; 770: 169-175.
42. Hara M, Kai Y, Ikemoro Y. Local anesthetics reduce the inhibitory neurotransmitter-induced current in dissociated hippocampal neurons of the rat. Eur J Pharmacol 1995; 283: 83-89.
43. Elliott AA, Harrold JA, Newman JP, Elliott JR. Open channel block and open channel destabilization: contrasting effects of phenol, TEA+ and local anaesthetics on Kv1.1 K+ channels. Toxicol Lett 1998; 100-101: 277-285.
44. Elliott AA, Elliott JR. Voltage-dependent inhibition of RCK1 K+ channels by phenol, p-cresol, and benzyl alcohol. Mol Pharmacol 1997; 51: 475-483.
45. Mohammadi B, Haeseler G, Leuwer M, et al. Structural requirements of phenol derivatives for direct activation of chloride currents via GABAA-receptors. Eur J Pharmacol 2001; 421: 85-91.
46. James R, Glen JB. Synthesis, biological evaluation, and preliminary structure-activity considerations of a series of alkylphenols as intravenous anesthetic agents. J Med Chem 1980; 23: 1350-1357.
47. Kruk I, Michalska T, Lichszteld K, Kladna A, Aboul-Enein HY. The effect of thymol and its derivatives on reactions generating reactive oxygen species. Chemosphere 2000; 41: 1059-1064.
48. Rosenberg PH, Alila A. Accumulation of thymol in halothane vaporizers. Anaesthesia 1984; 39: 581-583.
49. Jacobi CA, Wenger FA, Schmitz-Rixen T, Muller JM. Talc pleurodesis in recurrent pleural effusions. Langenbecks Arch Surg 1998; 383: 156-159.
50. Turler A, Gawenda M, Walter M. Palliative iodized talc pleurodesis with instillation via tube thoracostomy. Support Care Cancer 1997; 5: 61-63.

ANTI-INFECTIVE AGENTS, LOCAL, thymol; CHLORHEXANOLS, menthol; ION CHANNELS, sodium channel; TERPENES, menthol, thymol

© 2002 European Society of Anaesthesiology